Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International (HK:6855)
:6855
RESEARCH TOOLSreports
Total Valuation
Ascentage Pharma Group International has a market cap or net worth of HK$25.55B. The enterprise value is HK$24.06B.
Market CapHK$25.55B
Enterprise ValueHK$24.06B
Share Statistics
Ascentage Pharma Group International has 348,999,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding348,999,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ascentage Pharma Group International’s return on equity (ROE) is -1.53 and return on invested capital (ROIC) is -17.43%.
Return on Equity (ROE)-1.53
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-17.43%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee1.73M
Profits Per Employee-715.05K
Employee Count567
Asset Turnover0.37
Inventory Turnover4.41
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio80.60
Price to Fair Value48.81
Price to FCF-63.78
Price to Operating Cash Flow-60.09
PEG Ratio32.83
Income Statement
In the last 12 months, Ascentage Pharma Group International had revenue of 980.65M and earned -405.43M in profits. Earnings per share was -1.34.
Revenue980.65M
Gross Profit951.57M
Operating Income-378.80M
Pretax Income-395.25M
Net Income-405.43M
EBITDA-299.63M
Earnings Per Share (EPS)-1.34
Cash Flow
In the last 12 months, operating cash flow was -354.39M and capital expenditures -16.53M, giving a free cash flow of -370.92M billion.
Operating Cash Flow-354.39M
Free Cash Flow-370.92M
Free Cash Flow per Share-1.06
Dividends & Yields
Ascentage Pharma Group International pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change160.78%
50-Day Moving Average61.83
200-Day Moving Average46.24
Relative Strength Index (RSI)53.34
Average Volume (3m)6.36M
Important Dates
Ascentage Pharma Group International upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International as a current ratio of 1.26, with Debt / Equity ratio of 631.54%
Current Ratio1.26
Quick Ratio1.26
Debt to Market Cap0.13
Net Debt to EBITDA-1.36
Interest Coverage Ratio-5.88
Taxes
In the past 12 months, Ascentage Pharma Group International has paid 10.43M in taxes.
Income Tax10.43M
Effective Tax Rate-0.03
Enterprise Valuation
Ascentage Pharma Group International EV to EBITDA ratio is -44.39, with an EV/FCF ratio of -98.06.
EV to Sales13.56
EV to EBITDA-44.39
EV to Free Cash Flow-98.06
EV to Operating Cash Flow-119.45
Balance Sheet
Ascentage Pharma Group International has HK$1.26B in cash and marketable securities with ¥1.67B in debt, giving a net cash position of HK$407.29M billion.
Cash & Marketable SecuritiesHK$1.26B
Total Debt¥1.67B
Net CashHK$407.29M
Net Cash Per ShareHK$1.17
Tangible Book Value Per ShareHK$0.57
Margins
Gross margin is 97.03%, with operating margin of -38.63%, and net profit margin of -41.34%.
Gross Margin97.03%
Operating Margin-38.63%
Pretax Margin-40.31%
Net Profit Margin-41.34%
EBITDA Margin-30.55%
EBIT Margin-38.63%
Analyst Forecast
The average price target for Ascentage Pharma Group International is HK$73.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$73.00
Price Target Upside1.67% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast330.23%
EPS Growth Forecast59.68%